| pubmed-article:21358346 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0009247 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0025500 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0205127 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0031082 | lld:lifeskim |
| pubmed-article:21358346 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:21358346 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21358346 | pubmed:dateCreated | 2011-5-30 | lld:pubmed |
| pubmed-article:21358346 | pubmed:abstractText | Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers of mesothelioma. This study aims to examine the longitudinal behavior of SM and MPF in controls to gain insight in the optimal use of these biomarkers in screening. | lld:pubmed |
| pubmed-article:21358346 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21358346 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21358346 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21358346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21358346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21358346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21358346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21358346 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21358346 | pubmed:month | May | lld:pubmed |
| pubmed-article:21358346 | pubmed:issn | 1556-1380 | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:DelangheJoris... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:VansteelandtS... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:De VuystPaulP | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:KishiYoshiroY | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:BosquéeLionel... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:GermonpréPaul... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:NackaertsKris... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:ThimpontJoëlJ | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:HollevoetKevi... | lld:pubmed |
| pubmed-article:21358346 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:21358346 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21358346 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:21358346 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21358346 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21358346 | pubmed:pagination | 889-95 | lld:pubmed |
| pubmed-article:21358346 | pubmed:dateRevised | 2011-10-26 | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:meshHeading | pubmed-meshheading:21358346... | lld:pubmed |
| pubmed-article:21358346 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21358346 | pubmed:articleTitle | Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study. | lld:pubmed |
| pubmed-article:21358346 | pubmed:affiliation | Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium. kevin.hollevoet@ugent.be | lld:pubmed |
| pubmed-article:21358346 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21358346 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
